Aveanna Healthcare (AVAH) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
15 May, 2026Strategic vision and platform
Focus on transforming homecare value through a diversified, national platform serving pediatric, adult, and geriatric patients in 39 states.
Emphasis on high-quality clinical outcomes and enhanced value for payor and government partners.
Scaled national platform leverages data-driven results and value-based agreements to improve outcomes and reduce total care costs.
Investments in technology and government affairs support sustainable growth and operational efficiency.
Leadership and organizational structure
CEO, CFO, and Principal Accounting Officer have all held their roles since 2023, bringing experience from prior leadership positions in healthcare.
Leadership team has been instrumental in the formation and financial structuring of the organization.
Financial performance and guidance
2026 revenue guidance of $2.56–$2.58 billion, with a gross margin of 31.7% and adjusted EBITDA of $328–$332 million.
Q1 2026 revenue grew 15.9% year-over-year to $647.9 million, with adjusted EBITDA up 25.2% to $84.4 million.
Operating cash flow for Q1 2026 was $4.3 million, a $12.9 million improvement over the prior year.
Liquidity of $524.8 million as of April 2026, with $1.48 billion in variable rate debt and interest rate hedges in place.
Latest events from Aveanna Healthcare
- Q2 2026 revenue up 13.7%, net income up 49.1%, and full-year guidance raised.AVAH
Q2 2026 - 2026 revenue surpassed $2.68 billion, driven by organic growth, M&A, and value-based care initiatives.AVAH
Investor presentation - Double-digit growth sustained by payer partnerships, acquisitions, and disciplined cost management.AVAH
Bank of America Home Care Conference - Accelerated growth and margin expansion driven by acquisitions, payer strategy, and financial discipline.AVAH
46th Annual William Blair Growth Stock Conference - Q1 revenue and earnings surged, with raised guidance and a major pediatric care acquisition pending.AVAH
Q1 2026 - Double-digit revenue and profit growth in 2025, robust 2026 outlook, and major acquisition announced.AVAH
Q4 2025 - Raised 2025 guidance and strong Q3 results highlight scalable, value-based growth and margin stability.AVAH
44th Annual J.P. Morgan Healthcare Conference - Q2 revenue rose 7% to $505M, adjusted EBITDA up 27.3%, guidance raised for 2024.AVAH
Q2 2024 - Q1 2025 saw 14% revenue growth, 93% EBITDA rise, and raised full-year guidance.AVAH
Q1 2025